Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: A systematic review

21Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Esophageal cancer stenting offers symptomatic relief for patients suffering from dysphagia. There are limited data to support their use to relieve dysphagia and improve nutrition during neoadjuvant therapy with some concern that they may negatively impact oncological outcomes. The aim of this systematic review was to quantify the impact of esophageal stents on outcomes prior to resection with curative intent. A literature search was performed using Embase, Medline, PubMed, PubMed Central, the Cochrane library for articles pertaining to esophageal stent use prior to or during neoadjuvant chemotherapy or chemoradiotherapy in patients planned for curative esophagectomy. Data extracted included basic demographics, clinical, nutritional and oncologic outcomes. A total of 9 studies involving 465 patients were included. Esophageal stent use resulted in a significant improvement in mean dysphagia scores in the immediate post stent period but failed to demonstrate any positive changes in weight, body mass index (BMI) or albumin. Only 33% of stented patients ultimately progressed to potential curative surgical resection and stents were associated with reduced R0 resection rates and lower overall survival. This systematic review shows that, although esophageal stenting is associated with improvements in dysphagia during neoadjuvant therapy, their effect on improving patient nutritional status is less clear and they may be associated with poorer long-term oncological outcomes. Stents should be used with caution in patients who are being considered for potentially curative resection of esophageal malignancies and other strategies of nutritional supplementation should be considered.

References Powered by Scopus

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

53402Citations
N/AReaders
Get full text

Methodological index for non-randomized studies (Minors): Development and validation of a new instrument

5648Citations
N/AReaders
Get full text

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial

1999Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021

79Citations
N/AReaders
Get full text

Esophageal Cancer: An Updated Review

55Citations
N/AReaders
Get full text

Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia

43Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ahmed, O., Bolger, J. C., O’Neill, B., & Robb, W. B. (2020). Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: A systematic review. Diseases of the Esophagus, 33(1). https://doi.org/10.1093/dote/doz090

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

45%

Researcher 9

45%

Professor / Associate Prof. 1

5%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

62%

Nursing and Health Professions 5

24%

Environmental Science 2

10%

Social Sciences 1

5%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 24

Save time finding and organizing research with Mendeley

Sign up for free